Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Alison W Loren"'
Autor:
Matthew P. Connor, Neeharika Prathapa, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, Ximena Jordan Bruno, Catherine E. Lai, Alison W. Loren, Selina M. Luger, Andrew H. Matthews, Shannon R. McCurdy, Alexander E Perl, David L. Porter, Arlene Zeringue, Joseph H. Oved, Timothy S. Olson, Keith W. Pratz, Daria V. Babushok
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/d008abed804247ba80e253a0d5516959
Autor:
Rahul Banerjee, Alison W. Loren
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 272-275 (2021)
Abstract In a recent multicenter analysis, long geographic distances predicted loss to follow‐up (LTF) among allogeneic hematopoietic cell transplantation (HCT) survivors. We hypothesized that lower frequencies of patient interactions (including in
Externí odkaz:
https://doaj.org/article/5444351a586149dfbfda53f3ab4bef1a
Autor:
Matthew P. Connor, Alison W. Loren, Elizabeth O. Hexner, Mary Ellen Martin, Saar I. Gill, Selina M. Luger, James K. Mangan, Alexander E. Perl, Shannon R. McCurdy, Keith W. Pratz, Colleen Timlin, Craig W. Freyer, Alison Carulli, Christopher Catania, Jacqueline Smith, Lauren Hollander, Alexis M. Zebrowski, Edward A. Stadtmauer, David L. Porter, Noelle V. Frey
Publikováno v:
Transplantation and Cellular Therapy. 29:113-118
Patients with refractory or relapsed and refractory myeloid malignancies have a poor prognosis. Allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning (MAC) in patients with active, chemotherapy-refractory myeloid disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5dc190078edd5f8225903761044691
https://doi.org/10.1016/j.jtct.2022.10.027
https://doi.org/10.1016/j.jtct.2022.10.027
Autor:
Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert Peter Gale, Betty K. Hamilton, Navneet S. Majhail, Alison W. Loren
Publikováno v:
Blood Advances, Vol 2, Iss 9, Pp 1022-1031 (2018)
Abstract: Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with
Externí odkaz:
https://doaj.org/article/eb6763f7bff54d2a9f6cf9c3ac09fd21
Autor:
Craig W. Freyer, Daria V. Babushok, Noelle V. Frey, Saar I. Gill, Alison W. Loren, Selina M. Luger, Amit Maity, Mary Ellen Martin, John P. Plastaras, David L. Porter, Elizabeth O. Hexner
Publikováno v:
Transplantation and Cellular Therapy. 28:590-596
Allogeneic hematopoietic cell transplantation (alloHCT) is indicated for patients with intermediate-risk or high-risk myelofibrosis (MF) and remains the sole potential cure. Reduced-intensity conditioning (RIC) is commonly used because of older patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baeec43f964bec6e9adca74b34d1e5c1
https://doi.org/10.1016/j.jtct.2022.06.018
https://doi.org/10.1016/j.jtct.2022.06.018
Publikováno v:
American Society of Clinical Oncology Educational Book.
The management of cancer during pregnancy requires a patient-centered, multidisciplinary approach to balance maternal and fetal well-being given the rarity of this clinical scenario and lack of substantial data. Involvement of oncology and nononcolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7858510859d7bcf7f8462a9421e3861f
https://doi.org/10.1200/edbk_100037
https://doi.org/10.1200/edbk_100037
Autor:
Agrima Mian, Wei Wei, Rajshekhar Chakraborty, Jean C. Yi, Jaime M. Preussler, Brian T. Hill, Jan Cerny, Abhinav Deol, Theresa E. Hahn, Shahrukh K. Hashmi, Samantha Jaglowski, Heather S.L. Jim, Nandita Khera, Alison W. Loren, Joseph P. McGuirk, Bipin N. Savani, Patrick Stiff, Joseph P. Uberti, Victoria Whalen, John R. Wingard, Jana Reynolds, Shernan G Holtan, William A. Wood, K. Scott Baker, Karen L. Syrjala, Betty K. Hamilton, Navneet S. Majhail
Publikováno v:
Blood. 140:8019-8021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8db0ea7d8bea98aa2f7477ab6ca26fb
https://doi.org/10.1182/blood-2022-167411
https://doi.org/10.1182/blood-2022-167411
Autor:
Andrew Matthews, Alexander E. Perl, Selina M. Luger, Saar Gill, Catherine Lai, David L. Porter, Sarah Skuli, Ximena Jordan Bruno, Craig W. Freyer, Alison Carulli, Martin P. Carroll, Daria V. Babushok, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Alison W. Loren, Vikram R Paralkar, Ivan Maillard, Keith W. Pratz
Publikováno v:
Blood. 140:1022-1024
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebcf2d145574a9bd0825d8bf0bf00c9
https://doi.org/10.1182/blood-2022-168036
https://doi.org/10.1182/blood-2022-168036
Autor:
Cristian C. Taborda, Shannon H Gier, Avery W Stivale, Alexander E. Perl, Saar Gill, Daria V. Babushok, Elizabeth O. Hexner, Noelle V. Frey, Catherine Lai, Ximena Jordan Bruno, Mary Ellen Martin, Ivan Maillard, David L. Porter, Alison W. Loren, Keith W. Pratz, Selina M. Luger, Phyllis A. Gimotty, Shannon R. McCurdy
Publikováno v:
Blood. 140:10825-10827
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58024809a657cf599c62565f7a817c4b
https://doi.org/10.1182/blood-2022-169924
https://doi.org/10.1182/blood-2022-169924
Autor:
Andrew H. Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar I. Gill, David L. Porter, Daria V. Babushok, Ivan P. Maillard, Martin P. Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, Ximena Jordan Bruno, Wei-Ting Hwang, David Margolis, Keith W. Pratz
Publikováno v:
Blood Advances. 6:3997-4005
CPX-351 and venetoclax and azacitidine (ven/aza) are both indicated as initial therapy for acute myeloid leukemia (AML) in older adults. In the absence of prospective randomized comparisons of these regimens, we used retrospective observational data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c851f4812c33e17a6d75e9e78bc482
https://doi.org/10.1182/bloodadvances.2022007265
https://doi.org/10.1182/bloodadvances.2022007265